BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28336232)

  • 1. TGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signaling.
    Xiong S; Klausen C; Cheng JC; Leung PCK
    Cell Signal; 2017 Jun; 34():92-101. PubMed ID: 28336232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
    Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
    Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway.
    Pechkovsky DV; Scaffidi AK; Hackett TL; Ballard J; Shaheen F; Thompson PJ; Thannickal VJ; Knight DA
    J Biol Chem; 2008 May; 283(19):12898-908. PubMed ID: 18353785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1/2 signaling pathways.
    Xiong S; Cheng JC; Klausen C; Zhao J; Leung PC
    Oncotarget; 2016 Sep; 7(38):61262-61272. PubMed ID: 27542208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling.
    Xiong S; Klausen C; Cheng JC; Leung PC
    Oncotarget; 2016 Jun; 7(26):40060-40072. PubMed ID: 27223076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling.
    Li Y; Xie Y; Cui D; Ma Y; Sui L; Zhu C; Kong H; Kong Y
    Cell Physiol Biochem; 2015; 37(4):1503-12. PubMed ID: 26509489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line.
    Shang C; Lu YM; Meng LR
    Int J Gynecol Cancer; 2011 Jul; 21(5):795-9. PubMed ID: 21666489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.
    Hong SK; Park JR; Kwon OS; Kim KT; Bae GY; Cha HJ
    Cancer Lett; 2016 Jul; 376(2):339-46. PubMed ID: 27085460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
    Park DW; Choi KC; MacCalman CD; Leung PC
    Reprod Biol Endocrinol; 2009 Aug; 7():81. PubMed ID: 19656390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
    Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
    Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
    J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.
    Montagnani Marelli M; Moretti RM; Procacci P; Motta M; Limonta P
    Int J Oncol; 2006 Mar; 28(3):723-30. PubMed ID: 16465378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
    Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
    Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro.
    Patsenker E; Popov Y; Wiesner M; Goodman SL; Schuppan D
    J Hepatol; 2007 May; 46(5):878-87. PubMed ID: 17258347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
    Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
    J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
    Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
    Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of beta1-integrin enhances TGF-beta1-induced collagen expression in epithelial cells via increased alphavbeta3-integrin and Rac1 activity.
    Hayashida T; Jones JC; Lee CK; Schnaper HW
    J Biol Chem; 2010 Oct; 285(40):30741-51. PubMed ID: 20650890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
    Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.